Obstetrics & Gynaecology · Cervical Carcinoma (Risk Factors, Staging, Treatment)

Which HPV vaccine provides protection against the greatest number of oncogenic HPV types?

  • A Bivalent vaccine (HPV 16, 18)
  • B Quadrivalent vaccine (HPV 6, 11, 16, 18)
  • C Monovalent vaccine (HPV 16)
  • D Nonavalent vaccine (HPV 6, 11, 16, 18, 31, 33, 45, 52, 58)
Correct answer: D. Nonavalent vaccine (HPV 6, 11, 16, 18, 31, 33, 45, 52, 58)

Explanation

The nonavalent HPV vaccine protects against nine HPV types: 6, 11, 16, 18, 31, 33, 45, 52, and 58. It covers the two most common oncogenic types (16 and 18) plus five additional high-risk types (31, 33, 45, 52, 58), providing protection against approximately 90 percent of cervical cancers. The bivalent and quadrivalent vaccines cover fewer oncogenic types.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs

See all Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs →